Patent Notice

Last Updated: June 28, 2022

This web page satisfies the virtual patent marking provisions of various jurisdictions including the relevant provisions of the America Invents Act and provides the necessary notice in accordance with 35 U.S.C. § 287(a). The following ENDOQUEST products, platforms and technology are protected by patents in the United States and elsewhere. Additional patents and patent applications may also be pending in the United States and internationally.

Endoluminal Surgical (ELS) Platform or the use thereof.

The ELS System is under development, has not been cleared by the FDA and is not for commercial sale in the United States.